pharma · Multiple Myeloma · Relapsed/Refractory Multiple Myeloma
Janssen-Cilag International N.V
Janssen-Cilag International N.V.
NovaPharmaNews editorial coverage mentioning Janssen-Cilag International N.V — regulatory, clinical, and market analysis.
São Paulo, EU HQ
13 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- São Paulo, EU
- Employees
- 13
- Programs
- 161
- Drugs
- 159
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Janssen-Cilag International N.V — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Janssen-Cilag International N.V — regulatory, clinical, and market analysis.